Pharmacology - Pharmacology Xagena

Pharmacology

Home Page

Xagena Medicine

Xagena.net

New evidence on risks associated with Cox-2 inhibitors and NSAIDs

Stroke prevention in patients with non-valvular atrial fibrillation

ERK pathway: potential target for new pain therapies

Pharmacogenetics could reduce the incidence of adverse reactions and optimize treatments

Many patients on diuretics have abnormal sodium and potassium levels

Pharmacogenetics could reduce the incidence of adverse reactions and optimize treatments

Many patients on diuretics have abnormal sodium and potassium levels

Selective inhibitors of mPGES-1, a new class of anti-inflammatory drugs that might lessen chance of COX-2 cardiovascular events

EPA is inviting to reduce PFOA

Pharmacogenetics could reduce the incidence of adverse reactions and optimize treatments

Many patients on diuretics have abnormal sodium and potassium levels

Selective inhibitors of mPGES-1, a new class of anti-inflammatory drugs that might lessen chance of COX-2 cardiovascular events

Cocaine and amphetamine require CART, an neurotransmitter, to produce their maximal effects

FDA Advisory Panel recommends Tarceva approval for pancreatic cancer

Leprosy microbes provides insights into human immune responses

FDA warns against abuse of Dextromethorphan

Catalase enzyme prolongs mouse lifespan

Products derived from bees: serious adverse reactions

WHO: public health concern on acrylamide in food

EMEA, regulatory actions for the COX-2 inhibitor

Next Pages [1]

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions